Product Information
MEXILETINE 200 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2651 per EA under NDC 64980066701. Its NADAC has been published 44 times since Aug 27, 2025.
Strength
200 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980066701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215315On Market Since
2/5/2025
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 200 MG CAPSULE has been published 44 times since Aug 27, 2025, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2651 per EA |
|---|---|
| All-time high | $0.3155 (Sep 10, 2025) |
| All-time low | $0.2651 (Jun 17, 2026) |
| 52-week high | $0.3155 |
| 52-week low | $0.2651 |
| Median price | $0.2854 |
| Average price | $0.2862 |
| Largest weekly change | -7.4% (May 20, 2026) |
| Weeks tracked | 44 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 200 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2651 per EA (NDC 64980066701), effective Jun 24, 2026.
How has the price of MEXILETINE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 200 MG CAPSULE has declined 16.0%. It has been tracked across 44 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for MEXILETINE 200 MG CAPSULE?
Since Aug 27, 2025, the NADAC for MEXILETINE 200 MG CAPSULE has ranged from a low of $0.2651 (Jun 17, 2026) to a high of $0.3155 (Sep 10, 2025), with a median of $0.2854 per EA.
Are there cheaper alternatives to MEXILETINE 200 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 200 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 200 MG CAPSULE?
MEXILETINE 200 MG CAPSULE (NDC 64980066701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification